FDA Sees Drug Discovery Technology, Mergers Cutting Down On NDAs
Executive Summary
FDA believes novel drug discovery technologies are contributing to the reduction in "truly innovative applications," Center for Drug Evaluation & Research Deputy Director Steven Galson, MD, said